FindTrial
Sign In

Determine the Side Effects of Drugs Prescribed for Leprosy Treatment

Evaluation of Adverse Drug Reaction Profile of Drugs Prescribed for the Treatment of Leprosy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075228
Enrollment
35
Registered
2024-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A30- Leprosy [Hansens disease]

Interventions

Intervention1: Not Applicable: Not Applicable Control Intervention1: Not Applicable: Not Applicable

Sponsors

Dr Ravi Chandra C V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed leprosy subjects irrespective of age, gender and co-morbidities. 2. Patients completed or undergoing multidrug therapy or alternative drug regimens for paucibacillary (PB) and multibacillary (MB) leprosy. 3. Patients receiving treatment for the management of complications of leprosy. 4. Subjects willing to participate and providing the written informed consent for the study.

Exclusion criteria

Exclusion criteria: 1. Patients unwilling to participate and not furnishing the required informed consent for the study.

Design outcomes

Primary

MeasureTime frame
Adverse drug reaction profile (prevalence, causality, severity and preventability of drug reactions) of prescribed medications in the treatment of leprosy.Timepoint: 6 months—

Secondary

MeasureTime frame
Medication adherence to multidrug therapy (MDT)Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Satyaki Ganguly

All India Institute of Medical Sciences (AIIMS), Raipur

nitingaikwad2707@aiimsraipur.edu.in8518881725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026